Brazil: People waiting for Hep C cure caught between a life-changing decision – and an attempt to block it
Anvisa’s decision would allow the purchase of generics, and increase access to quality Hep C treatment – but a simultaneous...
Advocating for an improved patent applications process in Ukraine
The decision to grant or refuse a patent has an impact on the price of essential medicines – and huge...
Thai decision to ‘speed up’ drug patents would threaten access to medicines
Global community on access to medicines calls on Thai PM to retain a pro public health stance. The Thai...
Argentina: GEP filed new opposition to patent request for Hepatitis C drug
A significant step in ensuring access to treatment for the 800,000 people living with hepatitis C in Argentina. Earlier this...
All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/r
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine On 30 January...
Brazilian National Institute of Industrial Property Rejects Truvada® Patent Application
On 24 January 2017, Brazil’s National Institute of Industrial Property (INPI) made public a decision to reject the patent application...
Patent on HIV and Hepatitis drug TAF challenged in Ukraine
On 28 December 2016, the All-Ukrainian Network of People Living with HIV/AIDS submitted a patent invalidation claim against Gilead patent...
Debating patent law and access to medicines in Ukraine
Last month (9 December 2016), the All-Ukrainian Network of People Living with HIV/AIDS held a roundtable meeting on ‘Patent Law...
Open Letter to WHO Director General, Margaret Chan
Civil Society Open Letter urging WHO to include UN High Level Panel on Access to Medicines Report on WHO Board Agenda
Thai Activists and Hospital Staff Review Progress on HCV Treatment
Community groups and government hospital staff from eight provinces met to review access to medicines on 15 and 16 November. The...